Project Profile · IPA II · Competitiveness and Innovation
R&D Support Laboratory to Increase the Global Competitiveness of Life Sciences
Priority Area
Health-sector companies of all sizes wishing to carry out R&D in GMP-compliant controlled environments (especially SMEs developing biotechnological products and short- or long-term implantable medical materials); companies of all sizes developing new drugs and biotechnological products that need animal imaging tests and analyses (especially start-ups and SMEs); intermediary organisations (technology development zones, technology transfer offices, R&D centres)
Implementing Institution
Boğaziçi University
Partner Institutions
Marmara Medical Device Manufacturers and Suppliers Association (MASSİAD)
Duration
18 months, 01.11.2021
EU Contribution
€4,099,456
Location
All of Türkiye, with a focus on İstanbul
Project Objective
IPA II
The main objective of the project is to increase the necessary infrastructure capacity in health technologies – the sector with Türkiye’s second-largest current account deficit after energy – to support the R&D and product development work of entrepreneurs and SMEs working on medical devices and biotechnology products, and to reduce external dependency.
Results Achieved / Expected Outputs
Expected Outputs
- 01 Improved capacity and technical infrastructure of the three main units of the BULifeSci centre – the Clean Room Unit, the Test and Analysis Unit and the experimental animal (Vivarium) Unit – through analysis and imaging devices, special animal housing cages and clean room cabinets
- 02 Needs analyses, sector diagnostic studies, a business plan and centre strategies to strengthen BULifeSci’s existing infrastructure
- 03 Promotional activities
- 04 Research-oriented training for entrepreneurs and SMEs in biotechnology
Project profile · IPA II · Competitiveness and Innovation
All Competitiveness and Innovation Projects (IPA II)